ArticleNeuro-oncology2017

Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.

Deborah T Blumenthal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.